Expression Systems for Study of Mycobacterial Gene Regulation and Development of Recombinant BCG Vaccines
- 29 May 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 246 (3), 797-804
- https://doi.org/10.1006/bbrc.1998.8724
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.Proceedings of the National Academy of Sciences, 1995
- Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM seriesJournal of Bacteriology, 1994
- Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.Proceedings of the National Academy of Sciences, 1993
- Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.The Journal of Experimental Medicine, 1993
- Drug-resistant TB may bring epidemicNature, 1992
- New use of BCG for recombinant vaccinesNature, 1991
- Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vectorJournal of Bacteriology, 1990
- Tuberculosis and Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1989
- Lysogeny and transformation in mycobacteria: stable expression of foreign genes.Proceedings of the National Academy of Sciences, 1988
- Introduction of foreign DNA into mycobacteria using a shuttle phasmidNature, 1987